Complete remission in a patient with metastatic gastric cancer receiving tislelizumab combined with chemotherapy: a case report.

Zhu, Zhe; Dai, Pei-Lin; Han, Shuai; Qiu, Enming; Wang, Yu; Li, Zhou

Zhu, Zhe; Dai, Pei-Lin; Han, Shuai; Qiu, Enming; Wang, Yu; Li, Zhou.

Afiliación

Zhu Z; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Dai PL; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Han S; Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Qiu E; Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Wang Y; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Li Z; Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Front Oncol ; 13: 1147636, 2023.

Article en En | MEDLINE | ID: mdl-37234987

Palabras clave

advanced gastric cancer; case report; complete remission; immune checkpoint inhibitor; tislelizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google